Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical & Experimental Metastasis
Metadata
Title
Expression and function of the high affinity αIibβ3 integrin in murine melanoma cells
Authors
Jozsef Timar
Mohit Trikha
Karoly Szekeres
Rajesh Bazaz
Kenneth Honn
Publication date
01-07-1998
Publisher
Kluwer Academic Publishers
Published in
Clinical & Experimental Metastasis / Issue 5/1998
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1023/A:1006533508560

Other articles of this Issue 5/1998

Clinical & Experimental Metastasis 5/1998 Go to the issue

OriginalPaper

Functional consequences of cyclin D1 overexpression in human mammary luminal epithelial cells

OriginalPaper

Use of tumor lines with selectable markers in assessing the effect on experimental metastases of combination chemotherapy with alkylating agents

OriginalPaper

Alterative expression of the collagenase and adhesion molecules in the highly metastatic clones of human colonic cancer cell lines

OriginalPaper

Integrin α5β1: a potent inhibitor of experimental lung metastasis

OriginalPaper

Multiple effects of transfection with interleukin 2 and/or interferon γ on the behavior of mouse T lymphoma cells

OriginalPaper

Hypomethylation of the metastasis-associated S100A4 gene correlates with gene activation in human colon adenocarcinoma cell lines
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits